BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38822039)

  • 1. NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency.
    Liu X; Zhu H; Guo B; Chen J; Zhang J; Wang T; Zhang J; Shan W; Zou J; Cao Y; Wei B; Zhan L
    Sci Rep; 2024 May; 14(1):12447. PubMed ID: 38822039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
    J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
    Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
    Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
    Gan Q; Crumley S; Broaddus RR
    Int J Gynecol Pathol; 2019 Jan; 38(1):44-51. PubMed ID: 29210800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
    Zhan L; Zhang J; Zhang J; Liu X; Zhu S; Shi Y; He Y; Wang W; Fan Y; Tang Z; Chen G; Wei B; Cao Y
    Cancer Lett; 2022 Mar; 529():37-52. PubMed ID: 34974132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
    Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
    World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
    Glaire MA; Ryan NA; Ijsselsteijn ME; Kedzierska K; Obolenski S; Ali R; Crosbie EJ; Bosse T; de Miranda NF; Church DN
    J Pathol; 2022 Jul; 257(3):340-351. PubMed ID: 35262923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer.
    Zhan L; Zhang J; Wei B; Cao Y
    Autophagy; 2022 Apr; 18(4):942-943. PubMed ID: 35174769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP14 predicts poorer survival outcomes and promotes tumor progression in endometrial carcinoma by activating NF-κB signaling.
    Gong X; Jia L; Zhou L; Hu T
    Aging (Albany NY); 2023 Nov; 15(21):12120-12135. PubMed ID: 37917013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Clinicopathologic Analysis for Mismatch Repair Protein Expression in Unselected Endometrial Carcinoma Patients With an Emphasis on the Role of MLH1 Deficiency.
    Huang SW; Lin H; Huang CC; Ou YC; Fu HC; Tsai CC; Changchien CC; Wu CH
    Int J Gynecol Pathol; 2022 Jul; 41(4):407-416. PubMed ID: 34347667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.
    Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B
    Mod Pathol; 2021 May; 34(5):994-1007. PubMed ID: 33328602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRC5 negatively regulates LTA-induced inflammation via TLR2/NF-κB and participates in TLR2-mediated allergic airway inflammation.
    Wang M; Wang L; Fang L; Li S; Liu R
    J Cell Physiol; 2019 Nov; 234(11):19990-20001. PubMed ID: 30945291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The USP14-NLRC5 pathway inhibits titanium particle-induced osteolysis in mice by suppressing NF-κB and PI3K/AKT activities.
    Fang G; Fu Y; Li S; Qiu J; Kuang M; Lin S; Li C; Ding Y
    J Biol Chem; 2020 May; 295(20):7018-7032. PubMed ID: 32273344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.
    Zhan L; Zhang J; Zhang JH; Liu XJ; Guo B; Chen JH; Tang ZH; Wang WY; Wang QY; Wei B; Cao YX
    Biomark Res; 2023 Apr; 11(1):43. PubMed ID: 37085864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression.
    Zhu SD; Zhang J; Liu XJ; Zhang JH; Wei B; Wang WY; Fan YJ; Li D; Cao YX; Zhan L
    Technol Cancer Res Treat; 2022; 21():15330338221112742. PubMed ID: 35880269
    [No Abstract]   [Full Text] [Related]  

  • 16. NLRC5 promotes cell proliferation via regulating the NF-κB signaling pathway in Rheumatoid arthritis.
    Liu YR; Yan X; Yu HX; Yao Y; Wang JQ; Li XF; Chen RN; Xu QQ; Ma TT; Huang C; Li J
    Mol Immunol; 2017 Nov; 91():24-34. PubMed ID: 28865311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer.
    Mariya T; Kubo T; Hirohashi Y; Yanagawa J; Tabuchi Y; Matsuo K; Furumura K; Morita R; Nakatsugawa M; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Torigoe T
    Med Mol Morphol; 2021 Mar; 54(1):14-22. PubMed ID: 32410009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.
    Tong Y; Cui J; Li Q; Zou J; Wang HY; Wang RF
    Cell Res; 2012 May; 22(5):822-35. PubMed ID: 22473004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRC5 Mediates IL-6 and IL-1β Secretion in LX-2 Cells and Modulated by the NF-κB/Smad3 Pathway.
    Xu T; Ni MM; Huang C; Meng XM; He YH; Zhang L; Li J
    Inflammation; 2015 Oct; 38(5):1794-804. PubMed ID: 25820389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.